Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Shares Outstanding (Weighted Average) (2016 - 2017)

Historic Shares Outstanding (Weighted Average) for Bone Biologics (BBLG) over the last 2 years, with Q3 2017 value amounting to $3.9 million.

  • Bone Biologics' Shares Outstanding (Weighted Average) fell 8998.47% to $3.9 million in Q3 2017 from the same period last year, while for Sep 2017 it was $3.9 million, marking a year-over-year decrease of 8998.47%. This contributed to the annual value of $37.6 million for FY2016, which is N/A changed from last year.
  • Latest data reveals that Bone Biologics reported Shares Outstanding (Weighted Average) of $3.9 million as of Q3 2017, which was down 8998.47% from $3.9 million recorded in Q2 2017.
  • In the past 5 years, Bone Biologics' Shares Outstanding (Weighted Average) registered a high of $38.8 million during Q3 2016, and its lowest value of $3.9 million during Q2 2017.